openPR Logo
Press release

What's driving the Cancer Gene Therapy Market trends? Sibiono Genetech, Shanghai Sunway Biotech Co., LTD, Human Stem Cell Institute, Altor Bioscience Corporation, Amgen, BioCancell, Aduro Biotech, OncoGeneX, Celsion, GlobeImmune, Inc, New Link Geneticsm,

10-16-2019 07:29 PM CET | Industry, Real Estate & Construction

Press release from: marketstudyreport.com

/ PR Agency: marketstudyreport.com
Cancer Gene Therapy Market

Cancer Gene Therapy Market

A collective analysis on ‘Cancer Gene Therapy market’ by Market Study Report, LLC, offers an exhaustive study based on current trends influencing this vertical throughout assorted geographies. Key information regarding market size, market share, statistics, application, and revenue are compiled in the research to develop an ensemble prediction. In addition, this research offers a detailed competitive analysis focusing on business outlook emphasizing expansion strategies accepted by market majors.
Cancer Gene Therapy Market size is expected to exceed USD 4.3 billion by 2024; as per a new research report by. Globally, rising cancer prevalence will increase demand for gene therapy as the effective personalized treatment choice. According to WHO, cancer incidence is projected to rise by 50% to reach 15 million by the end of this decade. This alarming increase in number of patients necessitates this as a potential treatment approach addressing the growing global burden of the disease.

Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/467801?utm_source=openpr.com&utm_medium=Abhijeet

Key players include SiBiono, Altor Bioscience Corporation, Shanghai Sunway Biotech company limited, Amgen, BioCancell, OncoGeneX, Aduro Biotech, GlobeImmune, Inc., New Link Genetics., ZioPharm Oncology, MolMed, GENELUX, Gradalis, MultiVir.

Increased adoption of emerging genomic technologies such as NGS and high density micro array coupled with favorable government initiatives will fuel global cancer gene therapy market size. For instance, CDC supports nationwide screening programs for control of breast, cervical and colorectal cancer among low-income women with little or no health insurance. However, high cost of development lack of reimbursement and regulatory processes will restrain industry growth.

Growing number of clinical trials and availability of wide range of genes and vectors used in these trials will enable emergence of new treatment modalities to help make cancer a manageable disease. By the end of 2012, the number of clinical trials crossed 1,800 worldwide.

Adenoviral vector remains as the most common oncology application due to its competent nuclear mechanism and low pathogenicity. It is widely used in replacement approaches, suicide and gene-based immunotherapy, and syndicate with chemotherapy and is anticipated to grow at 20% CAGR.

Retroviral vector-mediated gene transfer dominated the development by enabling the conversion of single stranded RNA into a double stranded DNA molecule, which steadily integrates into the target cell genome. These vectors are used to permanently modify the host cell nuclear genome and will register a robust growth of over 20%.

U.S. led the industry owing to increased R&D funding and other government initiatives. Growing number of biotech companies are engaging in R&D and clinical trials of gene therapy products. Increased demand for DNA vaccines and increasing interest of venture capitalists to invest in commercialization of gene therapies will trigger industry expansion.

China cancer gene therapy market size attributed to over 35% APAC revenue in 2015. With the launch of Gendicine and increasing healthcare expenditure and robust R&D facilities will enable industry growth.

Key insights from the report include:

U.S. cancer gene therapy market share accounted for over 95% regional revenue in 2015, with market size of USD 235 million and a forecast to grow at 20.9% CAGR.
UK was over USD 92.0 million in 2015, and will grow at 20.8% CAGR owing to increasing incidence of cancer and adoption of advanced treatment methods.China market size was valued at USD 99.6 million in 2015 and growth expectations of 21% CAGR over the forecast years.

The industry is highly fragmented and is dominated by several small biotech firms collectively accounting for over 80% of cancer gene therapy market pipeline. Major growth strategies adopted by these small firms include, technology transfer, licensing and commercialization deals, strategic collaborations and mergers and acquisitions to retain their industry position.

Global Market Insights has segmented the cancer gene therapy industry on the basis of therapy type, and region

Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/467801?utm_source=openpr.com&utm_medium=Abhijeet

Cancer Gene Therapy Market Type Analysis

Gene induced immunotherapy

Delivery of cytokine gene
Delivery of Tumor antigen gene

Oncolytic Virotherapy

Adenoviruses
Lentiviruses
Retrovirus
Adeno Associated Virus
Herpes Simplex Virus
Alphavirus
Vaccinia Virus
Simian Virus

Gene transfer / Gene replacement

Naked/Plasmid Vectors
Electroporation
Sonoporation
Magnetofection
Gene Gun

Report Content

Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Cancer Gene Therapy Industry Insights
Chapter 4. Cancer Gene Therapy Insights
Chapter 5. Cancer Gene Therapy Regional Insights
Chapter 6. Company Profiles
6.1. Sibiono Genetech
6.2. Shanghai Sunway Biotech Co., LTD
6.3. Human Stem Cell Institute
6.4. Altor Bioscience Corporation
6.5. Amgen
6.6. BioCancell
6.7. Aduro Biotech
6.8. OncoGeneX
6.9. Celsion
6.10. GlobeImmune, Inc
6.11. New Link Genetics
6.12. Immuno Frontier, Inc.
6.13. MolMed S.p.A
6.14. Advantagene
6.15. Sevion Therapeutics
6.16. ZioPharm Oncology
6.17. Gradalis
6.18. AstraZeneca
6.19. OncoSec Medical Incorporated
6.20. Jennerex Biotherapeutics, Inc.
6.21. Nova Rx Corporation

buying decision on this premium report https://www.marketstudyreport.com/enquiry-before-buying/467801?utm_source=openpr.com&utm_medium=Abhijeet

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Cancer Gene Therapy Market trends? Sibiono Genetech, Shanghai Sunway Biotech Co., LTD, Human Stem Cell Institute, Altor Bioscience Corporation, Amgen, BioCancell, Aduro Biotech, OncoGeneX, Celsion, GlobeImmune, Inc, New Link Geneticsm, here

News-ID: 1850867 • Views: 168

More Releases from marketstudyreport.com

Clinical Laboratory Services Market By Regional Trend & Growth Forecast 2019-202 …
Market Study Report recently introduced new title on “Global Carbon Black Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates market outlook and status to 2025. The Latin America breast pump market accounted for more than 12% revenue share in 2018 and is assessed to witness a significant CAGR by 2025. This is due to the development in healthcare facilities
Sleep Apnea Devices Market - Growth, Trends, and Forecast (2019 - 2025)
Market Study Report recently introduced new title on “2019-2025 Global Sleep Apnea Devices Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates market outlook and status to 2025. Technological advancements in sleep apnea devices is a major market growth augmenting factor. Hypoglossal Nerve Stimulation (HNS), is a completely novel approach for treating obstructive sleep apnea. Moreover, growing alcohol intake in
What's driving the Structural Steel Market trends? ArcelorMittal, Tata Steel, Ni …
A detailed study on ‘Structural Steel market’ formulated by Market Study Report, LLC, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry’s size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in
What's driving the Industrial IoT (IIoT) Market trends? Rockwell Automation, ABB …
A detailed study on ‘Industrial IoT (IIoT) Market’ formulated by Market Study Report, LLC, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry’s size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors

All 5 Releases


More Releases for Gene

Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Hemophilia Gene Therapy - A Pipeline Analysis Report
"The Report Hemophilia Gene Therapy - A Pipeline Analysis Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Hemophilia Gene Therapy: An insight Hemophilia is an inherited bleeding disorder. The gene responsible for hemophilia is present on the X chromosome and is inherited in a recessive manner. Hemophilia A, also called as factor VIII (FVIII) deficiency or classic hemophilia, is caused by missing
Gene Synthesis Market Size 2017-2022 OriGene, Gene Oracle, Genescript
e Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded
Gene Therapy Drug Pipeline Analysis
“Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight
Cancer Gene Therapy Market Analysis
The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer. The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant
Global Gene Synthesis Market Research Report 2017
Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded annual